US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Chronic Bronchitis-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Emphysema-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Lung Infections-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Lung Injury-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Pulmonary Radiation Toxicity -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Respiratory Depression-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Respiratory Distress Syndrome-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Ventilator Associated Pneumonia (VAP)-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2016
8/10/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Severe Acute Respiratory Syndrome (SARS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
8/1/2016 | published by: GBI Research
... affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area ...  |  read more...
USD 4,995
Global Respiratory System Market Research Report 2016
8/5/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Respiratory System basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Germany Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market ...  |  read more...
USD 1,950
Italy Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market ...  |  read more...
USD 1,950
Japan Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers
7/8/2016 | published by: VPGMarketResearch.com
... shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market ...  |  read more...
USD 2,400
Respiratory Diseases Diagnostic Testing Market
7/1/2016 | published by: VPGMarketResearch.com
... shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on ...  |  read more...
USD 9,850
2016 U.S. Patient care - Respiratory system sold through Offices of physicians-Product & Services Report
5/15/2016 | published by: Barnes Reports
... report features 2016 current and 2017 forecast estimates on the sales of Patient care - Respiratory system sold through Offices of physicians nationally and for all 50 U.S. States and up to 900 metro areas.  |  read more...
USD 199
2016 U.S. Patient care - Respiratory system sold through Medical & surgical hospitals-Product & Services Report
5/15/2016 | published by: Barnes Reports
... features 2016 current and 2017 forecast estimates on the sales of Patient care - Respiratory system sold through Medical & surgical hospitals nationally and for all 50 U.S. States and up to 900 metro areas.  |  read more...
USD 199
Global Respiratory Care Devices Market (By Segment, By Devices, By Region: Opportunities and Forecasts (2016- 2021)(By Segment-Diagnostic, Monitoring, Therapeutics, Consumables; By Devices- Spirometers, DLCO, Pulse Oximeter, Gas Analysers, Capnographs, PA
5/1/2016 | published by: Azoth Analytics
... Concentrators, Inhalers, Filters, Mask and Cannulas) Executive Summary Due to rise in tobacco intake and rise in pollution with escalating CO2 emissions, market for Respiratory Care Devices is anticipated to rise by 10.90% up till ...  |  read more...
USD 2,400
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2016
5/18/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Respiratory Syncytial Virus (RSV) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 202
6/3/2016 | published by: MarketsandMarkets
... reach USD 5.77 billion by 2021 from USD 3.35 billion in 2016, growing at a CAGR of 11.5%, during 2016 to 2021. Market growth can be attributed to factors such as the technological advancements; rising ...  |  read more...
USD 5,650
Small-Cell Lung Cancer - Pipeline Review, H1 2016
5/25/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Small-Cell Lung Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
France Respiratory Diseases Diagnostic Testing Market
7/1/2016 | published by: VPGMarketResearch.com
... Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular ...  |  read more...
USD 1,950
Italy Respiratory Diseases Diagnostic Testing Market
7/1/2016 | published by: VPGMarketResearch.com
... Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular ...  |  read more...
USD 1,950
Spain Respiratory Diseases Diagnostic Testing Market
7/1/2016 | published by: VPGMarketResearch.com
... Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular ...  |  read more...
USD 1,950
1    3    5  6  7  8  9  10